Ֆամվիր

main_info

  • trade_name:
  • Ֆամվիր
  • dosage:
  • 125մգ(10/1x10/, ) բլիստերում
  • pharmaceutical_form:
  • դեղահատեր թաղանթապատ
  • prescription_type:
  • Դեղատոմսով
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • Ֆամվիր
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

27-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

FDA issues a request for information to solicit feedback on how consumers are using plant-based substitutes for milk, cheese and other dairy foods.

FDA - U.S. Food and Drug Administration

23-7-2018

Flowers Foods Issues Voluntary Recall on Mrs. Freshley’s and Other Brands of Swiss Rolls and Captain John Derst’s Old Fashioned Bread

Flowers Foods Issues Voluntary Recall on Mrs. Freshley’s and Other Brands of Swiss Rolls and Captain John Derst’s Old Fashioned Bread

As a precautionary measure, Flowers Foods, Inc. (NYSE: FLO) is voluntarily recalling Swiss Rolls sold under the brand names Mrs. Freshley’s, Food Lion, H-E-B, Baker’s Treat, Market Square, and Great Value, distributed nationwide, and Captain John Derst’s Old Fashioned Bread distributed in Alabama, Florida, Georgia, North Carolina, and South Carolina, due to the potential presence of Salmonella in an ingredient, whey powder. The ingredient recall was initiated by a third-party whey powder manufacturer and...

FDA - U.S. Food and Drug Administration

28-6-2018

Clinical Investigator Inspection List (CLIIL)

Clinical Investigator Inspection List (CLIIL)

The Clinical Investigator Inspection List contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investigational new drugs.

FDA - U.S. Food and Drug Administration

21-4-2006

Warning: Sale of illegal diet pills

Warning: Sale of illegal diet pills

Illegal diet pills containing the active substances ephedrine and ephedra are sold in a number of shops and on the internet. The illegal products are sold under names such as Therma Power

Danish Medicines Agency

12-4-2019


Referral: Estradiol-containing (0.01% w/w) medicinal products for topical use,  estradiol, associated names: Linoladiol,Linoladiol N,Linoladiol Estradiol,Estradiol Wolff,Montadiol, Article 31 referrals, Procedure started

Referral: Estradiol-containing (0.01% w/w) medicinal products for topical use,  estradiol, associated names: Linoladiol,Linoladiol N,Linoladiol Estradiol,Estradiol Wolff,Montadiol, Article 31 referrals, Procedure started

Referral: Estradiol-containing (0.01% w/w) medicinal products for topical use,  estradiol, associated names: Linoladiol,Linoladiol N,Linoladiol Estradiol,Estradiol Wolff,Montadiol, Article 31 referrals, Procedure started

Europe - EMA - European Medicines Agency

29-3-2019


Referral: Basiron AC and associated names, benzoyl peroxide, Article 13 referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/03/2019

Referral: Basiron AC and associated names, benzoyl peroxide, Article 13 referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/03/2019

Referral: Basiron AC and associated names, benzoyl peroxide, Article 13 referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/03/2019

Europe - EMA - European Medicines Agency

6-3-2019

Fortekor and associated names

Fortekor and associated names

Fortekor and associated names (Active substance: Benazepril hydrochloride) - Corrigendum - Commission Decision (2012)772 of Wed, 06 Mar 2019

Europe -DG Health and Food Safety

1-3-2019


Referral: Syner-Kinase and associated names, urokinase, Article 29(4) referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/02/2019

Referral: Syner-Kinase and associated names, urokinase, Article 29(4) referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/02/2019

Referral: Syner-Kinase and associated names, urokinase, Article 29(4) referrals, Opinion provided by Committee for Medicinal Products for Human Use, 28/02/2019

Europe - EMA - European Medicines Agency

1-2-2019

Diotop 75 mg / 20 mg modified-release capsules, hard and associated names

Diotop 75 mg / 20 mg modified-release capsules, hard and associated names

Diotop 75 mg / 20 mg modified-release capsules, hard and associated names (Active substance: diclofenac/omeprazole) - Community Referrals - Art 29 - Commission Decision (2019)845 of Fri, 01 Feb 2019 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1474

Europe -DG Health and Food Safety

21-1-2019

Diclofenac Sodium Spray Gel 4 % Cutaneous Spray, Solution and associated names

Diclofenac Sodium Spray Gel 4 % Cutaneous Spray, Solution and associated names

Diclofenac Sodium Spray Gel 4 % Cutaneous Spray, Solution and associated names (Active substance: Diclofenac sodium) - Community Referrals - Art 29 - Commission Decision (2019)589 of Mon, 21 Jan 2019 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1467

Europe -DG Health and Food Safety

14-1-2019

Paclitaxel Hetero and associated names

Paclitaxel Hetero and associated names

Paclitaxel Hetero and associated names (Active substance: paclitaxel) - Community Referrals - Art 29 - Commission Decision (2019)205 of Mon, 14 Jan 2019 European Medicines Agency (EMA) procedure number: EMEA/H//A-29(4)/1466

Europe -DG Health and Food Safety

19-12-2018

Perlinring and associated names

Perlinring and associated names

Perlinring and associated names (Active substance: etonogestrel/ethinylestradiol) - Community Referrals - Art 29 - Commission Decision (2018)9141 of Wed, 19 Dec 2018 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1473

Europe -DG Health and Food Safety

2-11-2018

Updating medicine ingredient names

Updating medicine ingredient names

New communication materials available

Therapeutic Goods Administration - Australia

27-8-2018

Discontinuing pre-market evaluation of Herbal Component Names: Frequently asked questions (FAQs)

Discontinuing pre-market evaluation of Herbal Component Names: Frequently asked questions (FAQs)

Frequently asked questions to inform sponsors about discontinuing the pre-market evaluation of HCNs

Therapeutic Goods Administration - Australia

27-8-2018

Submissions received: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Submissions received: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Submissions received on the Discontinuing pre-market evaluation of Herbal Component Names (HCNs) consultation have been published

Therapeutic Goods Administration - Australia

3-8-2018

Scandonest and associated names

Scandonest and associated names

Scandonest and associated names (Active substance: mepivacaine) - Community Referrals - Art 30 - Commission Decision (2018)5380 of Fri, 03 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/A-30/1455

Europe -DG Health and Food Safety